Intuitive Surgical, Inc. is a leading medical technology firm dedicated to advancing patient care by developing, producing, and commercializing sophisticated tools. These innovations empower medical professionals to deliver superior, accessible, and less-invasive treatment options to patients both within the United States and across international markets. Its flagship offering, the da Vinci Surgical System, facilitates intricate operations through a minimally disruptive approach. Expanding beyond surgical applications, the company also provides the Ion endoluminal system, designed for diagnostic interventions like minimally invasive lung biopsies. Complementing its primary systems, Intuitive Surgical supplies a comprehensive array of instruments, including stapling tools, energy devices, and essential core components. Furthermore, it offers structured training programs to ensure proficient use of its technology, alongside extensive customer support services encompassing installation, repairs, and ongoing maintenance. The firm also integrates digital capabilities to deliver unified, connected solutions that optimize hospital performance through actionable insights. Established in 1995, Intuitive Surgical maintains its corporate headquarters in Sunnyvale, California.

Intuitive Surgical (ISRG) Stock Price & Market Analysis
ISRG · NASDAQ · Medical - Instruments & Supplies
$449.53
▼ -$0.5100(-0.11%)4:00 PM ET - vs previous closeQuote as of Nov 11, 2026, 4:00 PM EST
Regular-session close · Nov 11, 2026, 4:00 PM EST.
Long-term rangesAvailable historyHide
Historical range: 2000-11-13–2026-11-11. Earlier trading may not be included.
Loading price chart…
Data dates
PriceAt closeLast traded
FundamentalsLast checked
AnalystLast checked
NewsLatest item
What matters next
Next important events
- Jan 21, 2027Next earnings (est.)Estimated
Countdown
70 days out
Reported fundamentals
ISRG financial overview
Annual revenue
USD 10.06B
Sales for the fiscal year ended Dec 31, 2025. This is not trailing twelve-month revenue.
Revenue change
+20.5%
Change versus the fiscal year ended Dec 31, 2024.
Net profit margin
28.4%
Net income divided by revenue for the fiscal year ended Dec 31, 2025. This is not the trailing margin.
These reported results describe the business’s recent scale and profitability. Compare cash generation and valuation before forming an investment view; historical growth is not a forecast.
Company · ProfileAbout Intuitive Surgical (ISRG)Sector, leadership, and how Intuitive Surgical earns its revenue.Healthcare
Intuitive Surgical
NASDAQ · ISRG · US
Company overview as of Nov 11, 2026.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Headquarters
- Sunnyvale, CA, United States
- Country
- US
- Employees
- 17,021
- CEO
- Mr. David J. Rosa
- Exchange
- NASDAQ
Business model & operating resultsExplore business exposure, reported operating measures and the figures behind growth and profitability claims.
Narrative versus numbers
Demand is expanding
Supporting observation: 21.7%
Year-over-year growth in the latest quarter. This differs from the fiscal-year revenue change shown above. · Source timestamp: Sep 30, 2026
Growth produces accounting profit
Supporting observation: 25.5%
Net margin; the source did not supply a reporting period. Do not compare this reading with the quarterly or fiscal-year figures above. A positive margin does not establish cash generation. · Source timestamp: Nov 11, 2026, 11:02 PM EST
The business generates cash after investment
Supporting observation: USD 1.11B
Latest free cash flow from the statement feed. It is not a forecast and may cover a different period from the fiscal-year figures above. · Source timestamp: Sep 30, 2026
These are explicit tests of individual claims, not an overall bull/bear rating. Demand growth can coexist with valuation, concentration and financing risk.
Operating measures
- Revenue
- $3.05Bquarter ended Sep 30, 2026
- Gross margin
- 68.4%quarter ended Sep 30, 2026
- Operating margin
- 19.4%quarter ended Sep 30, 2026
- EPS
- $1.49quarter ended Sep 30, 2026
- Capital expenditure
- $113.10Mquarter ended Sep 30, 2026
- Free cash flow
- $1.11Bquarter ended Sep 30, 2026
- Free cash flow margin
- 36.4%quarter ended Sep 30, 2026
- Operating cash / net income
- 2.34×quarter ended Sep 30, 2026
- Revenue growth year over year
- 21.7%quarter ended Sep 30, 2026
Competitors & comparisonsCompare industry peers, reporting periods and related funds. Business mix and valuation bases may differ.
Valuation & fund comparisonsExplore dated peer valuations, growth comparisons and related funds.
Governance & sustainability
Market closed
Regular hours: 9:30 AM–4:00 PM America/New_York
Next open: 2026-11-12 · 9:30 AM America/New_York
Exchange calendar includes scheduled holidays and early closes. Extended-session prices appear separately only when supplied by the quote source.
Shortcuts
With research tools focused: / search · W watchlist · C compare · F financials · E earnings · N news · T technicals · Esc close